Channelchek - Registration

ZOMDF

$0.05

(-1.3%)

FLWS

$5.42

(-1.45%)

ACCO

$3.82

(-2.05%)

ARLP

$27.31

(0.63%)

AUIAF

$0.18

(-8.5%)

AZZ

$86.86

(1.94%)

BTBT

$2.11

(0.96%)

BTM

$1.56

(-0.64%)

CVKD

$17.36

(3.33%)

LCE:CA

$0.37

(4.23%)

COCP

$1.65

(-3.45%)

CDRO

$7.24

(0.98%)

CVGI

$0.91

(-8.8%)

LODE

$2.22

(-2.2%)

CMTL

$1.39

(-2.8%)

CNDT

$2.13

(-0.93%)

CXW

$22.2

(-0.22%)

CMLS

$0.22

(8.98%)

DRCT

$0.64

(-4.73%)

DLHC

$3.57

(-1.11%)

SSP

$2.14

(1.9%)

ELDN

$3.28

(1.23%)

EVC

$1.88

(2.17%)

EDRY

$8.62

(-1.87%)

ESEA

$31.05

(-0.26%)

FAT

$2.69

(0.37%)

RAIL

$6.05

(-4.57%)

GDEV

$10.48

(0.92%)

GOVX

$1.02

(4.42%)

GOCO

$10.49

(2.14%)

GHM

$30.88

(-2.09%)

GLDD

$9.04

(-1.31%)

GYRE

$9.32

(2.76%)

HMENF

$1.25

(-0.24%)

III

$3.66

(0.83%)

IPOOF

$0.92

(0%)

KELYA

$11.47

(-0.69%)

KTOS

$33.5

(-0.27%)

LUCK

$9.36

(-0.74%)

MAIA

$1.86

(-7%)

MGROF

$0.79

(0%)

NTRB

$5.84

(9.77%)

OCGN

$0.71

(-1.6%)

PERF

$1.98

(4.76%)

QMCI

$0.15

(-6.13%)

RGP

$5.61

(2%)

SGA

$11.6

(0.87%)

SHWZ

$0.02

(80.18%)

SHIP

$5.79

(1.05%)

SLQT

$3.38

(2.74%)

SKYX

$1.18

(13.46%)

SNAL

$1.07

(-2.27%)

GEO

$30.32

(-0.85%)

ODP

$13.37

(0.38%)

TNXP

$17.03

(-4.43%)

TSQ

$6.66

(-0.6%)

TZOO

$12.52

(-6.01%)

UNCY

$0.65

(1.34%)

VVX

$50.05

(0.48%)

VNCE

$1.76

(-5.38%)

XELB

$2.38

(-5.93%)

ZOMDF

$0.05

(-1.3%)

FLWS

$5.42

(-1.45%)

channelchek-in

‌

4/28/2025

Merck KGaA to Acquire SpringWorks Therapeutics in $3.9 Billion Deal to Expand Rare Tumor Treatments

Merck KGaA, Darmstadt, Germany, is making a significant move to bolster its healthcare division, announcing plans to acquire U.S.-based SpringWorks Therapeutics for approximately $3.9 billion. The definitive agreement will see Merck pay $47 per share in cash, representing a 26% premium to SpringWorks’ 20-day average stock price before news of the deal first surfaced.

3 min read